Form 4: InnovAge Director Marilyn Tavenner Receives Equity Grant

InnovAge Holding Corp. Director Marilyn B Tavenner was granted 25,316 Restricted Stock Units (RSUs) on July 1, 2025, which will vest in full on June 30, 2026.

Summary

• Marilyn B Tavenner, a Director of InnovAge Holding Corp. (INNV), acquired 25,316 shares of common stock.
• The transaction occurred on July 1, 2025.
• These shares represent Restricted Stock Units (RSUs) with a transaction price of $0.
• The RSUs are scheduled to vest in full on June 30, 2026, contingent upon Ms. Tavenner's continued service with the Issuer.
• Following this transaction, Ms. Tavenner beneficially owns 45,157 shares of common stock.

Sentiment

Score: 6

Explanation: Slightly positive. The grant of RSUs to a director aligns their interests with shareholders, indicating continued commitment. This is a standard compensation event, not indicative of major operational changes, hence not highly positive, but certainly not negative.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction indicates continued commitment of a director to the company through future service requirements for vesting.

Negatives

• The transaction is a grant of RSUs, not an open market purchase, meaning there is no direct cash investment by the director at this time.
• The vesting of the RSUs is subject to continued service, meaning the shares are not immediately owned outright.

Risks

• The vesting of the 25,316 Restricted Stock Units is contingent upon the Reporting Person's continued service with InnovAge Holding Corp. until June 30, 2026.

Future Outlook

The 25,316 Restricted Stock Units are expected to vest in full on June 30, 2026, provided the Reporting Person continues their service with the Issuer.

Industry Context

Granting Restricted Stock Units (RSUs) to directors is a standard practice across various industries, particularly in publicly traded companies, to incentivize long-term commitment and align the interests of board members with shareholder value creation. This transaction is consistent with typical corporate governance and compensation strategies.

Comparison to Industry Standards

• Granting equity compensation, such as Restricted Stock Units (RSUs), to non-employee directors is a common and widely accepted practice in corporate governance across industries.
• This method is frequently employed by companies like Apple, Microsoft, and Google, among others, to align director incentives with long-term shareholder value.
• The specific number of units granted would typically be benchmarked against peer companies of similar size and complexity within the healthcare or technology sectors, though this document does not provide comparative data.
• The vesting schedule, contingent on continued service, is also a standard feature of such grants.

Related Party Transactions

• The acquisition of 25,316 Restricted Stock Units by Marilyn B Tavenner, a Director of InnovAge Holding Corp., represents a compensation transaction between the company and a related party (an insider). This is a standard form of director compensation.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the director's financial interests with the long-term performance of the company's stock, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• Continued service of Marilyn B Tavenner with InnovAge Holding Corp. until June 30, 2026.
• Vesting of 25,316 Restricted Stock Units on June 30, 2026.

Key Dates

Keywords

InnovAge Holding Corp., INNV, Marilyn B Tavenner, Director, Restricted Stock Units, RSUs, Equity Grant, Insider Transaction, SEC Form 4, Compensation